Aging, cytomegalovirus (CMV) and influenza vaccine responses

References

• Loerbroks A, Stock C, Bosch JA, Litaker DG, Apfelbacher CJ. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health 2012; 22:562-8; PMID:21750011; http://dx.doi.org/10.1093/eurpub/ckr094
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. Jama 2003; 289:179-86; PMID:12517228; http://dx.doi.org/10.1001/jama.289.2.179
   PubMed Web of Science ®Google Scholar
• Loerbroks ASC, Bosch JA, Litaker DG, Apfelbacher CJ. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health 2011; 22(4):562-8; PMID:21750011
   PubMed Web of Science ®Google Scholar
• Zimmerman RK, Lauderdale DS, Tan SM, Wagener DK. Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine 2010; 28:6470-7; PMID:20674882; http://dx.doi.org/10.1016/j.vaccine.2010.07.037
   PubMed Web of Science ®Google Scholar
• Ferrucci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997; 277:728-34; PMID:9042845; http://dx.doi.org/10.1001/jama.1997.03540330050034
   PubMed Web of Science ®Google Scholar
• Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montano LF, Nichol KL, Puig-Barbera J, Schmitt J, Stephenson I. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine 2009; 27:5043-53; PMID:19559118; http://dx.doi.org/10.1016/j.vaccine.2009.06.032
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Ewen C, Zhou X, Kane KP, Xie D, Hager WD, Barry MB, Kleppinger A, Wang Y, Bleackley RC. Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009; 27:2418-25; PMID:19368783; http://dx.doi.org/10.1016/j.vaccine.2009.01.136
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Zhou X, Talbot HK, Soethout E, Bleackley RC, Granville DJ, Pawelec G. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012; 30:2060-7; PMID:22289511; http://dx.doi.org/10.1016/j.vaccine.2012.01.015
   PubMed Web of Science ®Google Scholar
• McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983; 309:13-7; PMID:6602294; http://dx.doi.org/10.1056/NEJM198307073090103
   PubMed Web of Science ®Google Scholar
• Zhou X, McElhaney JE. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 2011; 29:2169-77; PMID:21353149; http://dx.doi.org/10.1016/j.vaccine.2010.12.029
   PubMed Web of Science ®Google Scholar
• Jenkins MR, Kedzierska K, Doherty PC, Turner SJ. Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. J Immunol 2007; 179:64-70; http://dx.doi.org/10.4049/jimmunol.179.1.64
   PubMed Web of Science ®Google Scholar
• Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984; 160:814-26; PMID:6206190; http://dx.doi.org/10.1084/jem.160.3.814
   PubMed Web of Science ®Google Scholar
• Swain SL, Dutton RW, Woodland DL. T cell responses to influenza virus infection: effector and memory cells. Viral Immunol 2004; 17:197-209; PMID:15279699; http://dx.doi.org/10.1089/0882824041310577
   PubMed Web of Science ®Google Scholar
• Topham DJ, Tripp RA, Doherty PC. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997; 159:5197-200
   PubMed Web of Science ®Google Scholar
• Brincks EL, Katewa A, Kucaba TA, Griffith TS, Legge KL. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol 2008; 181:4918-25; http://dx.doi.org/10.4049/jimmunol.181.7.4918
   PubMed Web of Science ®Google Scholar
• Finco O, Rappuoli R. Designing Vaccines for the Twenty-First Century Society. Front Immunol 2014; 5:12; PMID:24478777; http://dx.doi.org/10.3389/fimmu.2014.00012
   PubMed Web of Science ®Google Scholar
• Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, Abrutyn E. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002; 37:427-39; PMID:11772530; http://dx.doi.org/10.1016/S0531-5565(01)00210-8
   PubMed Web of Science ®Google Scholar
• Eto D, Lao C, DiToro D, Barnett B, Escobar TC, Kageyama R, Yusuf I, Crotty S. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PloS One 2011; 6:e17739; PMID:21423809; http://dx.doi.org/10.1371/journal.pone.0017739
   PubMed Web of Science ®Google Scholar
• Kroenke MA, Eto D, Locci M, Cho M, Davidson T, Haddad EK, Crotty S. Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol 2012; 188:3734-44; http://dx.doi.org/10.4049/jimmunol.1103246
   PubMed Web of Science ®Google Scholar
• Burlington DB, Clements ML, Meiklejohn G, Phelan M, Murphy BR. Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus. Infect Immun 1983; 41:540-5; PMID:6874068
   PubMed Web of Science ®Google Scholar
• McMurry JA, Johansson BE, De Groot AS. A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A. Hum Vaccin 2008; 4:148-57; PMID:18382131; http://dx.doi.org/10.4161/hv.4.2.5169
   PubMed Web of Science ®Google Scholar
• Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667-71; PMID:18449194; http://dx.doi.org/10.1038/nature06890
   PubMed Web of Science ®Google Scholar
• Corti D, Suguitan AL, Jr., Pinna D, Silacci C, Fernandez-Rodriguez BM, Vanzetta F, Santos C, Luke CJ, Torres-Velez FJ, Temperton NJ, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 2010; 120:1663-73; PMID:20389023; http://dx.doi.org/10.1172/JCI41902
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159-69; PMID:16213065; http://dx.doi.org/10.1016/j.vaccine.2005.08.105
   PubMed Web of Science ®Google Scholar
• McElhaney JE. Influenza vaccine responses in older adults. Ageing Res Rev 2010; 10(3):379-88; PMID:21055484
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol 2009; 21:418-24; PMID:19570667; http://dx.doi.org/10.1016/j.coi.2009.05.023
   PubMed Web of Science ®Google Scholar
• Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7:658-66; PMID:17897608; http://dx.doi.org/10.1016/S1473-3099(07)70236-0
   PubMed Web of Science ®Google Scholar
• Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 2007; 25:3066-9; PMID:17275144; http://dx.doi.org/10.1016/j.vaccine.2007.01.025
   PubMed Web of Science ®Google Scholar
• Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989–90 epidemic. Lancet 1995; 346:591-5; PMID:7651002; http://dx.doi.org/10.1016/S0140-6736(95)91434-X
   PubMed Web of Science ®Google Scholar
• Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988; 127:353-64; PMID:3337087
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40; PMID:15367555; http://dx.doi.org/10.1001/jama.292.11.1333
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518-27; PMID:7661497; http://dx.doi.org/10.7326/0003-4819-123-7-199510010-00008
   PubMed Web of Science ®Google Scholar
• Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:53-60; PMID:9652423; http://dx.doi.org/10.1086/515616
   PubMed Web of Science ®Google Scholar
• Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20:1831-6; PMID:11906772; http://dx.doi.org/10.1016/S0264-410X(02)00041-5
   PubMed Web of Science ®Google Scholar
• Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 2006; 24:6605-11; PMID:16806607; http://dx.doi.org/10.1016/j.vaccine.2006.05.063
   PubMed Web of Science ®Google Scholar
• Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331:778-84; PMID:8065407; http://dx.doi.org/10.1056/NEJM199409223311206
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li GM, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12:786-95; PMID:21743478; http://dx.doi.org/10.1038/ni.2067
   PubMed Web of Science ®Google Scholar
• Obermoser G, Presnell S, Domico K, Xu H, Wang Y, Anguiano E, Thompson-Snipes L, Ranganathan R, Zeitner B, Bjork A, et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 2013; 38:831-44; PMID:23601689; http://dx.doi.org/10.1016/j.immuni.2012.12.008
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001; 75:12182-7; PMID:11711609; http://dx.doi.org/10.1128/JVI.75.24.12182-12187.2001
   PubMed Web of Science ®Google Scholar
• Gupta S, Bi R, Su K, Yel L, Chiplunkar S, Gollapudi S. Characterization of naive, memory and effector CD8+ T cells: effect of age. Exp Gerontol 2004; 39:545-50; PMID:15050289; http://dx.doi.org/10.1016/j.exger.2003.08.013
   PubMed Web of Science ®Google Scholar
• Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, Caruso C, Franceschi C, Fulop T, Gupta S, et al. T cells and aging, January 2002 update. Front Biosci 2002; 7:d1056-183; PMID:11991846
   PubMed Web of Science ®Google Scholar
• Sridharan A, Esposo M, Kaushal K, Tay J, Osann K, Agrawal S, Gupta S, Agrawal A. Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity. Age 2011; 33:363-76; PMID:20953722; http://dx.doi.org/10.1007/s11357-010-9191-3
   PubMed Web of Science ®Google Scholar
• Chong Y, Ikematsu H, Yamaji K, Nishimura M, Nabeshima S, Kashiwagi S, Hayashi J. CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances. Int Immunol 2005; 17:383-90; PMID:15724062; http://dx.doi.org/10.1093/intimm/dxh218
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, Landin AM, Phillips M, Lechner SC, Ryan JG, Blomberg BB. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010; 28:8077-84; PMID:20974306; http://dx.doi.org/10.1016/j.vaccine.2010.10.023
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, Mendez NV, Landin AM, Ryan JG, Blomberg BB. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013; 31(35):3603-10; PMID:23711934
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, Phillips M, Mendez NV, Landin AM, Blomberg BB. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol 2012; 24:175-82; PMID:22281510; http://dx.doi.org/10.1093/intimm/dxr123
   PubMed Web of Science ®Google Scholar
• Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, Riley RL, Blomberg BB. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008; 180:5283-90; http://dx.doi.org/10.4049/jimmunol.180.8.5283
   PubMed Web of Science ®Google Scholar
• Shi Y, Yamazaki T, Okubo Y, Uehara Y, Sugane K, Agematsu K. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 2005; 175:3262-7; http://dx.doi.org/10.4049/jimmunol.175.5.3262
   PubMed Web of Science ®Google Scholar
• Frasca D, Blomberg BB. Effects of aging on B cell function. Curr Opin Immunol 2009; 21:425-30; PMID:19608393; http://dx.doi.org/10.1016/j.coi.2009.06.001
   PubMed Web of Science ®Google Scholar
• Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004; 5:133-9; PMID:14749784; http://dx.doi.org/10.1038/ni1033
   PubMed Web of Science ®Google Scholar
• Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity 2006; 24:491-4; PMID:16713963; http://dx.doi.org/10.1016/j.immuni.2006.05.003
   PubMed Web of Science ®Google Scholar
• Jing Y, Shaheen E, Drake RR, Chen N, Gravenstein S, Deng Y. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 2009; 70:777-84; PMID:19596035; http://dx.doi.org/10.1016/j.humimm.2009.07.005
   PubMed Web of Science ®Google Scholar
• Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010; 184:2518-27; http://dx.doi.org/10.4049/jimmunol.0901022
   PubMed Web of Science ®Google Scholar
• Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121:187-201; PMID:11164473; http://dx.doi.org/10.1016/S0047-6374(00)00210-4
   PubMed Web of Science ®Google Scholar
• Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009; 19:47-56; PMID:19035529; http://dx.doi.org/10.1002/rmv.598
   PubMed Web of Science ®Google Scholar
• Najarro K, Nguyen H, Chen G, Xu M, Alcorta S, Yao X, Zukley L, Metter EJ, Truong T, Lin Y, et al. Telomere Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza in Older Adults. J Infect Dis 2015; 212(8):1261-9.
   PubMed Web of Science ®Google Scholar
• Vallejo AN. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005; 205:158-69; PMID:15882352; http://dx.doi.org/10.1111/j.0105-2896.2005.00256.x
   PubMed Web of Science ®Google Scholar
• Derhovanessian E, Theeten H, Hahnel K, Van Damme P, Cools N, Pawelec G. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 2013; 31:685-90; PMID:23196209; http://dx.doi.org/10.1016/j.vaccine.2012.11.041
   PubMed Web of Science ®Google Scholar
• Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, Parson W, Bock G, Schonitzer D, Trannoy E, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168:5893-9; http://dx.doi.org/10.4049/jimmunol.168.11.5893
   PubMed Web of Science ®Google Scholar
• Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004; 10:119-24; PMID:15102354; http://dx.doi.org/10.1016/j.molmed.2004.01.002
   PubMed Web of Science ®Google Scholar
• Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko V, Currier NL, Nikolich-Zugich D, Kaye J, Nikolich-Zugich J. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 2014; 192:2143-55; http://dx.doi.org/10.4049/jimmunol.1301721
   PubMed Web of Science ®Google Scholar
• Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 2003; 3:939-51; PMID:14647476; http://dx.doi.org/10.1038/nri1248
   PubMed Web of Science ®Google Scholar
• Lewis DE, Yang L, Luo W, Wang X, Rodgers JR. HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells. Aids 1999; 13:1029-33; PMID:10397532; http://dx.doi.org/10.1097/00002030-199906180-00005
   PubMed Web of Science ®Google Scholar
• Martinez-Taboada VM, Goronzy JJ, Weyand CM. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis. Clin Immunol Immunopathol 1996; 79:263-70; PMID:8635285; http://dx.doi.org/10.1006/clin.1996.0078
   PubMedGoogle Scholar
• Neil GA, Summers RW, Cheyne BA, Carpenter C, Huang WL, Waldschmidt TJ. Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry. Dig Dis Sci 1994; 39:1900-8; PMID:8082496; http://dx.doi.org/10.1007/BF02088123
   PubMed Web of Science ®Google Scholar
• Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996; 97:2027-37; PMID:8621791; http://dx.doi.org/10.1172/JCI118638
   PubMed Web of Science ®Google Scholar
• Ferguson SE, Han S, Kelsoe G, Thompson CB. CD28 is required for germinal center formation. J Immunol 1996; 156:4576-81.
   PubMed Web of Science ®Google Scholar
• Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993; 261:609-12; PMID:7688139; http://dx.doi.org/10.1126/science.7688139
   PubMed Web of Science ®Google Scholar
• Lanna A, Henson SM, Escors D, Akbar AN. The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat Immunol 2014; 15:965-72; PMID:25151490; http://dx.doi.org/10.1038/ni.2981
   PubMed Web of Science ®Google Scholar
• Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013; 493:338-45; PMID:23325216; http://dx.doi.org/10.1038/nature11861
   PubMed Web of Science ®Google Scholar
• Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL. The origins of age-related proinflammatory state. Blood 2005; 105:2294-9; PMID:15572589; http://dx.doi.org/10.1182/blood-2004-07-2599
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908:244-54; PMID:10911963; http://dx.doi.org/10.1111/j.1749-6632.2000.tb06651.x
   PubMed Web of Science ®Google Scholar
• Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128:92-105; PMID:17116321; http://dx.doi.org/10.1016/j.mad.2006.11.016
   PubMed Web of Science ®Google Scholar
• Franceschi C, Valensin S, Bonafe M, Paolisso G, Yashin AI, Monti D, De Benedictis G. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol 2000; 35:879-96; PMID:11053678; http://dx.doi.org/10.1016/S0531-5565(00)00172-8
   PubMed Web of Science ®Google Scholar
• van Duin D, Allore HG, Mohanty S, Ginter S, Newman FK, Belshe RB, Medzhitov R, Shaw AC. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis 2007; 195:1590-7; PMID:17471428; http://dx.doi.org/10.1086/516788
   PubMed Web of Science ®Google Scholar
• Derhovanessian E, Larbi A, Pawelec G. Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr Opin Immunol 2009; 21:440-5; PMID:19535233; http://dx.doi.org/10.1016/j.coi.2009.05.012
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. High TNF-α levels in resting B cells negatively correlate with their response. Exp Gerontol 2014; 54:116-22; PMID:24440385; http://dx.doi.org/10.1016/j.exger.2014.01.004
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine 2015; 33:1433-9; PMID:25659271; http://dx.doi.org/10.1016/j.vaccine.2015.01.071
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, Mendez NV, Landin AM, Ryan JG, Blomberg BB. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013; 31:3603-10; PMID:23711934; http://dx.doi.org/10.1016/j.vaccine.2013.05.003
   PubMed Web of Science ®Google Scholar
• Sayegh CE, Quong MW, Agata Y, Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 2003; 4:586-93; PMID:12717431; http://dx.doi.org/10.1038/ni923
   PubMed Web of Science ®Google Scholar
• Frasca D, Landin AM, Alvarez JP, Blackshear PJ, Riley RL, Blomberg BB. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol 2007; 179:918-27; http://dx.doi.org/10.4049/jimmunol.179.2.918
   PubMed Web of Science ®Google Scholar
• Goebel P, Janney N, Valenzuela JR, Romanow WJ, Murre C, Feeney AJ. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J Exp Med 2001; 194:645-56; PMID:11535632; http://dx.doi.org/10.1084/jem.194.5.645
   PubMed Web of Science ®Google Scholar
• Quong MW, Harris DP, Swain SL, Murre C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J 1999; 18:6307-18; PMID:10562543; http://dx.doi.org/10.1093/emboj/18.22.6307
   PubMed Web of Science ®Google Scholar
• Quong MW, Romanow WJ, Murre C. E protein function in lymphocyte development. Annu Rev Immunol 2002; 20:301-22; PMID:11861605; http://dx.doi.org/10.1146/annurev.immunol.20.092501.162048
   PubMed Web of Science ®Google Scholar
• Sayegh CE, Quong MW, Agata Y, Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 2003; 4:586-93; PMID:12717431; http://dx.doi.org/10.1038/ni923
   PubMed Web of Science ®Google Scholar
• Schlissel M, Voronova A, Baltimore D. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev 1991; 5:1367-76; PMID:1714414; http://dx.doi.org/10.1101/gad.5.8.1367
   PubMed Web of Science ®Google Scholar
• Khurana S, Frasca D, Blomberg B, Golding H. AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans. PLoS Pathog 2012; 8:e1002920; PMID:23028320; http://dx.doi.org/10.1371/journal.ppat.1002920
   PubMed Web of Science ®Google Scholar
• Boyd SD, Liu Y, Wang C, Martin V, Dunn-Walters DK. Human lymphocyte repertoires in ageing. Curr Opin Immunol 2013; 25:511-5; PMID:23992996; http://dx.doi.org/10.1016/j.coi.2013.07.007
   PubMed Web of Science ®Google Scholar
• Gibson KL, Wu YC, Barnett Y, Duggan O, Vaughan R, Kondeatis E, Nilsson BO, Wikby A, Kipling D, Dunn-Walters DK. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009; 8:18-25; PMID:18986373; http://dx.doi.org/10.1111/j.1474-9726.2008.00443.x
   PubMed Web of Science ®Google Scholar
• Ademokun A, Wu YC, Martin V, Mitra R, Sack U, Baxendale H, Kipling D, Dunn-Walters DK. Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell 2011; 10:922-30; PMID:21726404; http://dx.doi.org/10.1111/j.1474-9726.2011.00732.x
   PubMed Web of Science ®Google Scholar
• Jiang N, He J, Weinstein JA, Penland L, Sasaki S, He XS, Dekker CL, Zheng NY, Huang M, Sullivan M, et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013; 5:171ra19; PMID:23390249; http://dx.doi.org/10.1126/scitranslmed.3004794
   PubMed Web of Science ®Google Scholar
• Dunn-Walters DK, Ademokun AA. B cell repertoire and ageing. Curr Opin Immunol 2010; 22:514-20; PMID:20537880; http://dx.doi.org/10.1016/j.coi.2010.04.009
   PubMed Web of Science ®Google Scholar
• Lund FE, Hollifield M, Schuer K, Lines JL, Randall TD, Garvy BA. B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol 2006; 176:6147-54; http://dx.doi.org/10.4049/jimmunol.176.10.6147
   PubMed Web of Science ®Google Scholar
• Menard LC, Minns LA, Darche S, Mielcarz DW, Foureau DM, Roos D, Dzierszinski F, Kasper LH, Buzoni-Gatel D. B cells amplify IFN-gamma production by T cells via a TNF-α-mediated mechanism. J Immunol 2007; 179:4857-66; http://dx.doi.org/10.4049/jimmunol.179.7.4857
   PubMed Web of Science ®Google Scholar
• Wojciechowski W, Harris DP, Sprague F, Mousseau B, Makris M, Kusser K, Honjo T, Mohrs K, Mohrs M, Randall T, et al. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity 2009; 30:421-33; PMID:19249230; http://dx.doi.org/10.1016/j.immuni.2009.01.006
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811; PMID:10837075; http://dx.doi.org/10.1146/annurev.immunol.18.1.767
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588
   PubMed Web of Science ®Google Scholar
• Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins TP, Siconolfi B, Meng H, Devine L, Raddassi K, Tsang S, et al. Prolonged Proinflammatory Cytokine Production in Monocytes Modulated by Interleukin 10 After Influenza Vaccination in Older Adults. J Infect Dis 2014; 211(7):1174-84.
   PubMed Web of Science ®Google Scholar
• Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol 2012; 24:507-11; PMID:22541724; http://dx.doi.org/10.1016/j.coi.2012.04.002
   PubMed Web of Science ®Google Scholar
• Pawelec G, Derhovanessian E. Role of CMV in immune senescence. Virus Res 2011; 157:175-9; PMID:20869407; http://dx.doi.org/10.1016/j.virusres.2010.09.010
   PubMed Web of Science ®Google Scholar
• Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Lofgren S, Ernerudh J, Pawelec G, Ferguson F, Johansson B. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 2006; 127:695-704; PMID:16750842; http://dx.doi.org/10.1016/j.mad.2006.04.003
   PubMed Web of Science ®Google Scholar
• Haspot F, Lavault A, Sinzger C, Laib Sampaio K, Stierhof YD, Pilet P, Bressolette-Bodin C, Halary F. Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PloS One 2012; 7:e34795; PMID:22496863; http://dx.doi.org/10.1371/journal.pone.0034795
   PubMedGoogle Scholar
• Freeman RB Jr. The ‘indirect’ effects of cytomegalovirus infection. Am J Transplant 2009; 9:2453-8; PMID:19843027; http://dx.doi.org/10.1111/j.1600-6143.2009.02824.x
   PubMed Web of Science ®Google Scholar
• Prosch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk HD, Kruger DH. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology 1995; 208:197-206; PMID:11831701; http://dx.doi.org/10.1006/viro.1995.1143
   PubMed Web of Science ®Google Scholar
• Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, Brydak LB, Machala M, Mysliwski A. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination–an impact of immunosenescence. Vaccine 2003; 21:3826-36; PMID:12922116; http://dx.doi.org/10.1016/S0264-410X(03)00309-8
   PubMed Web of Science ®Google Scholar
• Turner JE, Campbell JP, Edwards KM, Howarth LJ, Pawelec G, Aldred S, Moss P, Drayson MT, Burns VE, Bosch JA. Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age 2014; 36:287-97; PMID:23846127; http://dx.doi.org/10.1007/s11357-013-9557-4
   PubMed Web of Science ®Google Scholar
• Derhovanessian E, Maier AB, Hahnel K, McElhaney JE, Slagboom EP, Pawelec G. Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol 2014; 193:3624-31; http://dx.doi.org/10.4049/jimmunol.1303361
   PubMed Web of Science ®Google Scholar
• den Elzen WP, Vossen AC, Cools HJ, Westendorp RG, Kroes AC, Gussekloo J. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine 2011; 29:4869-74; PMID:21497631; http://dx.doi.org/10.1016/j.vaccine.2011.03.086
   PubMed Web of Science ®Google Scholar
• Furman D, Jojic V, Sharma S, Shen-Orr SS, Angel CJ, Onengut-Gumuscu S, Kidd BA, Maecker HT, Concannon P, Dekker CL, et al. Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med 2015; 7:281ra43; PMID:25834109; http://dx.doi.org/10.1126/scitranslmed.aaa2293
   PubMed Web of Science ®Google Scholar
• Pera A, Campos C, Corona A, Sanchez-Correa B, Tarazona R, Larbi A, Solana R. CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PloS One 2014; 9:e88538; PMID:24533103; http://dx.doi.org/10.1371/journal.pone.0088538
   PubMedGoogle Scholar
• Critchfield JW, Lemongello D, Walker DH, Garcia JC, Asmuth DM, Pollard RB, Shacklett BL. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J Virol 2007; 81:5460-71; PMID:17344302; http://dx.doi.org/10.1128/JVI.02535-06
   PubMed Web of Science ®Google Scholar
• Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, Ambrozak DR, Asher TE, Douek DC, Harari A, Pantaleo G, et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 2007; 204:1405-16; PMID:17535971; http://dx.doi.org/10.1084/jem.20062363
   PubMed Web of Science ®Google Scholar
• Derhovanessian E, Maier AB, Hahnel K, Zelba H, de Craen AJ, Roelofs H, Slagboom EP, Westendorp RG, Pawelec G. Lower proportion of naive peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people. Age 2013; 35:1387-99; PMID:22661297; http://dx.doi.org/10.1007/s11357-012-9425-7
   PubMed Web of Science ®Google Scholar
• Wang C, Liu Y, Xu LT, Jackson KJ, Roskin KM, Pham TD, Laserson J, Marshall EL, Seo K, Lee JY, et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol 2014; 192:603-11; http://dx.doi.org/10.4049/jimmunol.1301384
   PubMed Web of Science ®Google Scholar
• Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004; 104:3664-71; PMID:15304389; http://dx.doi.org/10.1182/blood-2004-05-2058
   PubMed Web of Science ®Google Scholar
• Caligiuri MA. Human natural killer cells. Blood 2008; 112:461-9; PMID:18650461; http://dx.doi.org/10.1182/blood-2007-09-077438
   PubMed Web of Science ®Google Scholar
• Nielsen CM, White MJ, Bottomley C, Lusa C, Rodriguez-Galan A, Turner SE, Goodier MR, Riley EM. Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals. J Immunol 2015; 194:4657-67; http://dx.doi.org/10.4049/jimmunol.1403080
   PubMed Web of Science ®Google Scholar